Skip to content
10-K

Annual Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-14-000021

← back to feed
Filed
Sep 8, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Aug 21, 2014 111.55M sh
Operating Cash Flow FY 2014 · Jun 30, 2014 −$105.41K
Operating Cash Flow FY 2014 · Jun 30, 2014 −$2.19M
Operating Cash Flow FY 2014 · Jun 30, 2013 −$206.47K
Operating Cash Flow FY 2014 · Jun 30, 2012 −$178.24K
Cash And Equivalents FY 2014 · Jun 30, 2014 $2.38K
Cash And Equivalents FY 2014 · Jun 30, 2013 $7.05K
Stockholders Equity FY 2014 · Jun 30, 2014 −$2.23M
Stockholders Equity FY 2014 · Jun 30, 2013 −$2.05M
Stockholders Equity FY 2014 · Jun 30, 2012 −$2.08M
Stockholders Equity FY 2014 · Jun 30, 2009 −$1.29M
Stockholders Equity FY 2014 · Jun 30, 2008 −$1.42M
Stockholders Equity FY 2014 · Jun 30, 2007 −$1.31M
Stockholders Equity FY 2014 · Oct 31, 2006 −$829.07K
Stockholders Equity FY 2014 · Oct 31, 2005 −$288.36K
Stockholders Equity FY 2014 · Oct 31, 2004 −$135.02K
Stockholders Equity FY 2014 · Jul 13, 2004 $1
Total Liabilities FY 2014 · Jun 30, 2014 $2.24M
Total Liabilities FY 2014 · Jun 30, 2013 $2.07M
Current Assets FY 2014 · Jun 30, 2014 $8.97K
Current Assets FY 2014 · Jun 30, 2013 $12.26K
Net Income FY 2014 · Jun 30, 2014 −$116.93K
Net Income FY 2014 · Jun 30, 2014 −$2.18M
Net Income FY 2014 · Jun 30, 2013 −$209.9K
Net Income FY 2014 · Jun 30, 2012 −$179.38K
Net Income FY 2014 · Jun 30, 2008 $62.3K
Net Income FY 2014 · Jun 30, 2007 −$377.13K
Net Income FY 2014 · Oct 31, 2006 −$508.26K
Net Income FY 2014 · Oct 31, 2005 −$387.67K
Net Income FY 2014 · Oct 31, 2004 −$128.49K
Operating Income FY 2014 · Jun 30, 2014 −$116.93K
Operating Income FY 2014 · Jun 30, 2014 −$2.46M
Operating Income FY 2014 · Jun 30, 2013 −$209.08K
Operating Income FY 2014 · Jun 30, 2012 −$179.38K